Evoq Remedies Ltd - Reg. 34 (1) Annual Report.
07 Feb 2024
Pursuant to Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are submitting herewith the Revised Annual Report for Financial Year 2021-22 due to discrepancy related to Related Parties Transactions in the Audit report.
Further this is to inform you that we were already submitted Annual Report for the Financial Year 2021-22, for the rectification the discrepancy we are submitting this revised Annual Report.
There is no change in Annual Report other than Addition in Annexure in Directors report i.e. Annexure 3 and Disclosure of Related Parties transactions.
Kindly take this revised Annual Report on your record and oblige us.
Thanking You.
Source:
BSE India